Bio-Connect

Goat anti-DLC1 (Isoforms 1 and 3)

Research Use Only
EB06436
Everest Biotech
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Porcine
TargetDLC1
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-DLC1 (Isoforms 1 and 3) Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Immunofluorescence: Expression of the protein seen in the cytoplasm and nucleus of U251 and U2OS cells. Recommended concentration: 10microg/ml.
  • Applications
    ImmunoFluorescence, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Pep-ELISA, IF, IHC
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID10395
  • Target name
    DLC1
  • Target description
    DLC1 Rho GTPase activating protein
  • Target synonyms
    ARHGAP7; deleted in liver cancer 1 protein; deleted in liver cancer 1 variant 2; deleted in liver cancer variant 4; epididymis secretory sperm binding protein; HP; p122-RhoGAP; rho GTPase-activating protein 7; Rho-GTPase-activating protein 7; rho-type GTPase-activating protein 7; STARD12; StAR-related lipid transfer (START) domain containing 12; START domain-containing protein 12
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_872584.2; NP_079043.3. GeneIDs all Nonhuman: 50768 (mouse);. Purification: Antigen affinity purified. Names and symbols: DLC1; HP; ARHGAP7; STARD12; FLJ21120; p122-RhoGAP; deleted in liver cancer 1; Rho-GTPase-activating protein 7; START domain containing protein 12; StAR-related lipid; transfer protein 12; StAR-related lipid transfer (START) domain containing 12; deleted
  • Reactivity
    Human, Mouse, Porcine
  • Reactivity Supplier
    Human, Mouse, Pig
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma. Ko FC et al., 2010 Jan, Liver Int
    Read more